Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study was to describe neurologists' population of patients treated with pramipexole and suffering from Parkinson's disease (so called 'primary care' population).

The secondary objectives were:

• Evaluate the mean dose of pramipexole prescribed under actual conditions of use depending on the severity of the disease.

• Evaluate the reasons for choosing pramipexole as treatment.

• Identify the patient profiles determining the choice of dose of pramipexole prescribed

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Pramipexole

Criteria

Inclusion Criteria:

• Patients suffering from idiopathic Parkinson's Disease and treated with pramipexole for at least two months, examined in consultation

Exclusion Criteria:

• Patient refusing to take part

• Patient taking part in a clinical trial